The FDA has granted Fast Track designation to AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy.

Completion of enrollment marks a key milestone toward satisfying FDA post-approval requirements. DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Na ...

Microchip Technology (Nasdaq: MCHP) today announces the LX4580, a 24‑channel mixed‑signal IC designed to streamline ...

AI protein function prediction uses machine learning models trained on sequence and structural data to infer protein roles at ...

However, airflow patterns, insulation consistency, and attic conditions reveal how the system supports interior ...

QUEENS, NY - Individuals involved in car accidents often experience little to no pain immediately following the ...

Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...

Garfield Township, Michigan - February 27, 2026 - PRESSADVANTAGE - Stephen Twomey has published a new educational ...

The U.S. Preventive Services Task Force’s state of uncertainty is threatening preventive health care in the country, ...

Ongoing PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

An ultimate guide and career roadmap to becoming a CFO, with skills and advice from experienced finance leaders.